Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

The incidence and prevalence of ILD vary globally. In a review of epidemiologic studies, the incidence ranged from 1.0 to 31.5 per 100,000 person-years, and the prevalence ranged from 6.27 to 80.9 per ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider Jeffrey J. Swigris, ...

While recalling the guidance of her mentor, Chidinma Chima-Melton, MD, emphasizes the necessity of taking a comprehensive patient history because interstitial lung disease is often misdiagnosed early.

After being hospitalized for three months with COVID-19 and double pneumonia in 2020, Houston police officer Hito Bazan awoke one morning to discover that he couldn't talk, eat, walk, or most ...

A steering committee of pulmonary experts and primary care physicians (PCPs) released today a white paper outlining the issues surrounding delays in diagnosing interstitial lung diseases (ILDs) like ...

Analysts note that the ILD Treatment Market is poised for significant expansion over the next decade, with a compound annual growth rate (CAGR) expected in the high single digits. While high treatment ...